MBE Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

MBE Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$396K	Sell	587 -25	-4%	-$14.9K	0.14%	105
2026 Q2	$307K	Buy	612 +6	+1%	+$2.88K	0.11%	123
2026 Q1	$298K	Hold	606	–	–	0.12%	111
2025 Q4	$351K	Sell	606 -12	-2%	-$6.79K	0.15%	91
2025 Q3	$300K	Buy	+618	New	+$288K	0.13%	103
2025 Q1	–	Sell	-394	Closed	-$205K	–	126
2024 Q4	$205K	Sell	394 -884	-69%	-$486K	0.12%	98
2024 Q3	$791K	Buy	1,278 +32	+3%	+$18.9K	0.44%	34
2024 Q2	$689K	Sell	1,246 -441	-26%	-$253K	0.42%	35
2024 Q1	$981K	Sell	1,687 -1,932	-53%	-$1.08M	0.61%	29
2023 Q4	$1.92M	Hold	3,619	–	–	0.98%	13
2023 Q3	$1.83M	Hold	3,619	–	–	1.05%	11
2023 Q2	$1.89M	Hold	3,619	–	–	1.02%	14
2023 Q1	$2.09M	Hold	3,619	–	–	1.23%	11
2022 Q4	$1.99M	Hold	3,619	–	–	1.29%	10
2022 Q3	$1.84M	Hold	3,619	–	–	1.34%	9
2022 Q2	$1.97M	Hold	3,619	–	–	1.37%	10
2022 Q1	$2.14M	Hold	3,619	–	–	1.27%	10
2021 Q4	$2.42M	Hold	3,619	–	–	1.24%	9
2021 Q3	$2.07M	Hold	3,619	–	–	1.05%	10
2021 Q2	$1.83M	Sell	3,619 -18	-0.5%	-$8.49K	0.95%	11
2021 Q1	$1.66M	Hold	3,637	–	–	0.9%	17
2020 Q4	$1.69M	Buy	3,637 +12	+0.3%	+$5.63K	1.15%	14
2020 Q3	$1.31M	Hold	3,625	–	–	1.1%	16
2020 Q2	$1.31M	Buy	3,625 +3,336	+1,154%	+$1.12M	1.1%	16
2020 Q1	$81K	Buy	+289	New	+$91.1K	0.08%	80

Other funds holding TMO

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

MBE Wealth Management's TMO Position: Q3 2026 in Review

MBE Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 4.1% in Q3 2026, selling an estimated $14.9K and leaving 587 shares worth $396K. The position accounts for 0.14% of the portfolio, ranked #105.

MBE Wealth Management first reported a position in TMO in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.42M in Q4 2021. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

MBE Wealth Management held 587 shares of Thermo Fisher Scientific worth $396K as of Q3 2026.
MBE Wealth Management sold 25 Thermo Fisher Scientific shares in Q3 2026, an estimated $14.9K.
Thermo Fisher Scientific made up 0.14% of MBE Wealth Management's portfolio in Q3 2026, its #105 holding.
MBE Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 25 quarters since.
MBE Wealth Management's Thermo Fisher Scientific position peaked at $2.42M in Q4 2021.
1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on MBE Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.